ADVERTISEMENT
ADVERTISEMENT

Entrepreneur Briefs

Cambridge BioScience hopes to turn its first profit this year with a new kit to detect Lyme disease, a tick-borne illness that can lead to serious neurological ailmerrts. The firm, founded in 1981 by Harvard molecular biologist William Haseltine, has marketed several enzyme immunoassay tests, including two for the presence of the HIV-1 antibody. Its Human Lyme EIA kit detects the IgM and lgG antibodies that indicate the presence of Lyme disease. The firm Interpreting AIDS Research For Laypeopl

The Scientist Staff

Cambridge BioScience hopes to turn its first profit this year with a new kit to detect Lyme disease, a tick-borne illness that can lead to serious neurological ailmerrts. The firm, founded in 1981 by Harvard molecular biologist William Haseltine, has marketed several enzyme immunoassay tests, including two for the presence of the HIV-1 antibody. Its Human Lyme EIA kit detects the IgM and lgG antibodies that indicate the presence of Lyme disease. The firm

Interpreting AIDS Research For Laypeople

A year ago, with the Fourth International Conference on AIDS in Stockholm imminent, cell biologist Bridget Wallace recognized that the way the information from the meeting was disseminated offered an opportunity for a new business. As things stood then, scientists were able to hear the latest findings firsthand, or could read about them in journals. The public learned through the popular press, in a general way, about the new developments. What...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
ADVERTISEMENT